Indonesia – SIGMA Medizin-Technik GmbH supported after local distributor and provided intensive training for its employees.
Our application specialist Mr. Waleed Zeitoun traveled to our Indonesian distributor Graha Ismaya from 23rd March to 17th April, 2018. In a workshop, Mr. Zeitoun trained the employees of our distributor in using NEUROWERK equipment and deepened their existing knowledge.
Graha Ismaya has been a very good partner for SIGMA Medizin-Technik GmbH in the past and was able to sell several NEUROWERK devices in the Indonesian market. Due to a pending registration in the e-catalouge of Indonesia, our local distributor was unfortunately not able to offer our EEG and EMG devices for some time. This registration process is now completed successfully. Full of motivation, Graha Ismaya has acquired two complete demo systems to present NEUROWERK products as best as possible. In order for future product presentations to be successfully implemented by the employees of our distributor, our application specialist traveled to the exclusive workshop. Mr. Zeitoun comprehensively trained the employees of our partner in handling the hardware and software of our NEUROWERK EEG and EMG systems, showed them tricks and functions. During the subsequent testing of the devices in the application, the participants in the course became more and more confident and thus optimally deepened their already acquired knowledge.
Dr. Irfan, also employed by Graha Ismaya as product manager, was accompanied by Waleed Zeitoun on two appointments to Indonesian hospitals. Together, they presented product systems from SIGMA Medizin-Technik in the RSUD Achmad Mochtar Hospital in Bukittinggi and RSUD ProfDr M Ali Hanafiah Hospital in Batusangkar. Doctors and hospital staff of both institutions were very impressed by the demonstrations and the product quality.
We are very happy about this positive response. Graha Ismaya and SIGMA Medizin-Technik GmbH will continue their good cooperation in the future and hope to receive many orders from Indonesia. We would like to thank Dr. Mohammad Irfan and his team.